🇫🇷
France · FR · FR:66859849
ORLADEYO 150 mg, gélule
ReimbursedATC B06AC
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerBIOCRYST IRELAND LIMITED (IRLANDE)
CountryFR (France)
ATC codeB06AC
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009302273814 plaquettes ACLAR RX) polytrifluorochloroéthylène PVC aluminium de 7 gélulesEUR 12.31
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "66859849",
"date_amm": "2021-04-30",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/21/1544",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code B06AC.
- PLAndembryCSL Behring GmbH
- 🇺🇸ANDEMBRYCSL
- 🇪🇸ANDEMBRY 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADACsl Behring Gmbh
- GBAndembry 200mg/1.2ml solution for injection pre-filled pensCSL Behring UK Ltd
- PLDawnzeraOtsuka Pharmaceutical Netherlands B.V.
- 🇺🇸DAWNZERAIonis Pharmaceuticals Inc.
- 🇪🇸DAWNZERA 80 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAOtsuka Pharmaceutical Netherlands B.V.
- DKEkterlyKalvista Pharmaceuticals (Ireland) Limited
Access this data programmatically
Query ORLADEYO 150 mg, gélule and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.